Arda Kara
Angel Investor
San Francisco, United States
Arda Kara is a Series A investor in San Francisco focused on Health Care and Medical. Arda Kara
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Arda Kara invests in
Stages Arda Kara invests in
Countries Arda Kara invests in
Round sizes
Round size
- Series A
- $26M–$38M
Investment Focus
Industry
- Health Care 7 (78%)
- Medical 3 (33%)
- Software 3 (33%)
- Biotechnology 3 (33%)
- Wellness 2 (22%)
Stage
- Series A 4 (44%)
- Seed 1 (11%)
- Series B 1 (11%)
- Series D 1 (11%)
- Convertible Note 1 (11%)
Country
- United States 7 (78%)
- Germany 1 (11%)
- Switzerland 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Levels
|
Levels develops a health and wellness platform designed to monitor metabolic fitness. The platform tracks blood glucose in real-time, enabling users to optimize their diet and exercise. The company was founded in 2019 and is a remote-first company. | $38M / Series A / Apr 20, 2022 | |
Blackrock Neurotech
|
Blackrock Neurotech’s mission is to provide innovative tools and neurotech expertise to translate technology into a novel, implantable clinical solutions that improve human lives. | Convertible Note / Nov 01, 2021 | |
Human API
|
Human API is a real-time health data network that gives consumers a simple way to view and share their health data from everywhere - regardless of how or where that data was collected, processed, or stored. The company provides a single, secure connection to data from 90% of US hospitals, electronic medical records, pharmacies, and labs, along with300+ wearable devices and wellness apps. Consumers are in full control of what companies they share their health data with, and companies have one easy way to access fragmented health data sources.It was founded in 2013 and is based in San Mateo, California. | Venture - Series Unknown / Nov 01, 2021 | |
Akute Health
|
Akute Health develops patient management software for doctors in async and membership healthcare. Akute Health's platform features CRM, ticket management, and automation all in the EHR. | $372.5K / Seed / Oct 30, 2021 | |
Mindbloom
|
Mindbloom is a mental health and wellbeing brand helping people achieve personal and clinical breakthroughs with at-home, clinician-prescribed psychedelic therapies. The company provides science-backed medicine designed by leading psychiatrists and facilitated by friendly, expert guides. | Series B / Sep 01, 2021 | |
Gilgamesh Pharmaceuticals
|
Gilgamesh Pharmaceuticals focuses on developing therapeutics that target neuropsychiatric and central nervous system conditions using small molecules derived from research on psychedelic compounds. The company designs and tests compounds that aim to modulate brain pathways involved in mental health disorders while reducing hallucinogenic effects.Its pipeline includes drug candidates intended for conditions such as depression, anxiety, and substance use disorders. Gilgamesh Pharmaceuticals conducts preclinical and clinical studies to evaluate the safety, dosing, and efficacy of its compounds. The company integrates medicinal chemistry, neuroscience, and clinical research to support drug development and regulatory progression. | $27M / Series A / May 06, 2021 | |
Alto Neuroscience
|
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most. | $32M / Series A / May 03, 2021 | |
AtaiBeckley
|
ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany. | $157M / Series D / Mar 03, 2021 | |
Centenara Labs
|
Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan. | $25M / Series A / Dec 01, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Arda Kara invest in?
Arda Kara invests primarily in Health Care, Medical and Software startups, most often at Series A and Seed stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Arda Kara's check size?
Arda Kara typically joins rounds of $26M–$38M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Arda Kara participates in.
When did Arda Kara last invest?
The most recent investment recorded for Arda Kara closed in Apr 2022. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
